1. Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates. Part 1;Lohr;Am. Pharmaceut. Rev.,2001
2. Chemical and analytical characterization of related organic impurities in drugs;Gorog;Anal. Bioanal. Chem.,2003
3. “International conference on harmonization (ICH) Guidelines,” Q3A (R) Impurities in New Drug Substances, February 2002.
4. Pharmaceutical impurities: an overview;Rao;Indian J. Pharmaceut. Educ. Res.,2010
5. S. Keitel, Impurity Profiles in Active Pharmaceutical Ingredients. EU /Swissmedic GMP Workshop Beijing University, Sep 2006.